J&J Bit Off More Than McNeil Could Chew In 2006 Pfizer OTC Acquisition
McNeil scaled up its manufacturing “volume and complexity substantially” following J&J’s acquisition of Pfizer’s consumer business in 2006, says McNeil Consumer VP Shane Freedman. “Just a few years later, we had the recalls” that led eventually to a consent decree with FDA,” he says.
Johnson & Johnson’s acquisition of Pfizer Inc.’s consumer products business in 2006 proved too big for the quality-control capacity of its OTC manufacturing, according to executives with J&J’s McNeil Consumer Healthcare subsidiary.
The $16 billion deal “was the largest acquisition in Johnson & Johnson’s history” at the time. “We scaled up our...
